Names | |
---|---|
IUPAC name
2-(Acetylamino)-glutaramidic acid
|
|
Other names | |
Identifiers | |
3D model (JSmol)
|
|
ChemSpider | |
DrugBank | |
ECHA InfoCard | 100.017.862 |
EC Number | 219-647-7 |
KEGG | |
MeSH | aceglutamide |
PubChem CID
|
|
UNII | |
|
|
|
|
Properties | |
C7H12N2O4 | |
Molar mass | 188.18 g·mol−1 |
Appearance | White crystals |
Melting point | 197 °C (387 °F; 470 K) |
Related compounds | |
Related alkanoic acids
|
|
Related compounds
|
|
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
|
|
Infobox references | |
Aceglutamide (brand name Neuramina), or aceglutamide aluminum (brand name Glumal), also known as acetylglutamine, is a psychostimulant, nootropic, and antiulcer agent that is marketed in Spain and Japan. It is an acetylated form of the amino acid L-glutamine, the precursor of glutamate in the body and brain. Aceglutamide functions as a prodrug to glutamine with improved potency and stability. Aceglutamide is used as a psychostimulant and nootropic, while aceglutamide aluminum is used in the treatment of ulcers. Aceglutamide can also be used as a liquid-stable source of glutamine to prevent damage from protein energy malnutrition. The drug has shown neuroprotective effects in an animal model of cerebral ischemia.